What Happened to Lowering the Cost of Drugs?

Pro Pharma Talks

1. Goal: Lower drug cost so that they are affordable to patients

a. US Rate of Inflation (2017-2019) = 2.14% to 1.8%

b. CPI = 2.0%

c. CPI (health care) = 2.8% (2019)

2. Drug Cost Transparency

a. Transparency = cost

b. CA SB17: WAC >= $40 with 16% inflation in prior year, or 32% inflation in last 2 years

3. How do they differ? Are they effective? Pros/Cons

a. White House Plan

b. Congressional Action

c. Congress – Democratic Plan

4. State Plans – What are they trying to do? Pros/Cons

a. California

b. New York

5. Discount Programs

a. GoodRx

b. TimesRx

c. Misc.

6. PhRMA unregulated for innovation

a. Largest PhRMA produce 11% of leading new Rx

b. New Rx develo9ped by universities, academic centers, NIH, hospital research groups

c. 2/3 of new Rx developed by France, Germany, Japan, Switzerland and UK

d. Raw materials from China, India, Israel, Brazil, South Africa, Australia

7. Transparency

a. Shoppable vs. urgent

b. Uwe Reinhardt – Priced Out – health care spending increases private sector > public sector

c. Gag Order Bans (half-of-states)

d. 8 States – PhRMA must provide reasons for reasoning for drug cost decisions

_____

Make sure to subscribe to get the latest episode.

Contact Us:

Pharmacy Benefit News: http://www.propharmaconsultants.com/pbn.html

Email: [e-mail]

Website: http://www.propharmaconsultants.com/

Facebook: https://www.facebook.com/propharmainc

Twitter: https://twitter.com/ProPharma/

Instagram: https://www.instagram.com/propharmainc/

LinkedIn: https://www.linkedin.com/company/pro-pharma-pharmaceutical-consultants-inc/

Podcast: https://anchor.fm/pro-pharma-talks